Tags

, , , , , , , , , , , ,

On the Tuesday, July 5th, 2011 broadcast at 8PM Pacific and 11PM Eastern, we re-visit the Avastin decision, and explore some of the issues surrounding the FDA’s choice to ‘hedge’ (a formal decision is pending later this month) the unanimous 6 to 0 panel recommendation to revoke fast track approval of the drug for the treatment of late stage breast cancer.

Some context on the decision can be viewed here, here and here.

To join us live or via archived replay of this exploration of a very timely and rather thorny issue, click here.

Advertisements